Research comparing clinical outcomes between patients receiving nafcillin and cefazolin for treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia shows that overall treatment ...

Beta-lactams are superior to vancomycin for definitive therapy, but not empiric treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infection, according to a large ...

Research reveals cost-effective alternative treatment for MSSA infections In a study of 142 patients with Methicillin-susceptible Staphylococcus aureus infections, researchers found that treatment ...

Linezolid Nosocomial pneumonia, cSSSI Oral and intravenous form available, bacteriostatic, not approved for catheter-related bloodstream infections, side effects include myelosuppression, ...

Cefazolin offers reduced mortality and similar recurrence rates vs. the penicillinase-stable penicillins (PSPs) nafcillin or oxacillin in patients with methicillin-susceptible Staphylococcus aureus ...

Cefazolin is a first‐generation cephalosporin widely used in the treatment of infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). Its favourable safety profile and reduced risk ...

Clearance for these sample types will double the accessible market for KeyPath™ to more than 90% of U.S. hospitals. On May 6, 2011, MicroPhage received initial 510(k) clearance from the U.S. Food and ...

Background. Antistaphylococcal penicillins are the treatment of choice for methicillin-susceptible Staphylococcus aureus (MSSA) infection. Ceftriaxone can be dosed once daily and is less expensive for ...

Methicillin-susceptible Staphylococcus aureus is as much of a risk to very low birth weight infants as methicillin-resistant S. aureus, but does not receive equal prevention and treatment measures.

Drug-resistant staph infections continue to be deadlier than those that are not resistant and treatable with traditional antibiotics, but treatment costs surprisingly are the same or slightly less, a ...